突发公共卫生事件时期医院科技论文发表管理思考--以新型冠状病毒肺炎孕产妇研究为例

Scientific publication management during the public health pandemic:Case analysis of the studies involving COVID-19 pregnant women

目的以国内学者发表的新型冠状病毒肺炎孕产妇病例报告和病例系列类研究文献为例,探讨新形势下医院科技论文发表规范化管理的要求。方法通过对我国新型冠状病毒肺炎初期国内学者发表病例报告和病例系列类文献进行检索,采用文献计量学方法对纳入文献的研究时间、研究内容及研究对象等信息进行统计分析。结果累计报道的360例孕产妇病例中,有近200例(55%)孕产妇病例无法完全排除被重复报道的可能,且相关文献中均未在文中声明可能的病例重复报道情况。结论未明确声明病例的重复报道会对后期进行荟萃分析造成偏倚,影响指南制定。医院科研管理部门应重点加强对科技论文中病例数据的管理,使其更好地服务于对疾病特征、疫情形势的准确评估以及诊治指南、防控策略的科学制定。

Objective Based on the analysis of case report and case series studies involving COVID-19 pregnant women in China,we aimed to discuss the updated management requirements for publication of scientific papers at hospitals in the new circumstances and context.Methods The case report and case series studies published by domestic scholars in the early stage of COVID-19 outbreak were retrieved.Bibliometrics were used to analyze the research time,research content and research objects of the included literatures.Results Nearly 200 cases(55%)of the 360 cases of COVID-19 pregnant women could not be clearly excluded from the possibility of repeated reporting.However,all these cases were not disclosed in the paper for possible repeated report.Conclusions Potential repeated report problem may cause trouble for later meta-analysis,which also may have negative impact for the development of clinical guidelines.The departments of scientific research management at hospital should pay more attention to the management of patient′s data in scientific papers,so that it can better serve the accurate assessment of disease characteristics and epidemic situation,as well as the scientific formulation of clinical guidelines and control strategies.